{"transactions":[{"id":1388773,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-10-09T11:46:52.000Z","date":"2024-10-08","kind":"purchase","planned":false,"acquired":true,"shares":5431,"price":0.9099,"value":4941.6669,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Adjusted to reflect 1-for-18 reverse stock split effective April 19, 2024."}],"balance_after":8638,"source":{"system":"sec-edgar","filing":"0001437749-24-030918","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774924030918/rdgdoc.xml","form_type":"4"}},{"id":1449617,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Warrants (Right to Buy)","published_at":"2024-07-24T21:27:47.000Z","date":"2024-07-22","kind":"grant","planned":false,"acquired":true,"shares":4011,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Purchase Agreement, the Reporting Person acquired 4,011 warrants to purchase 4,011 shares of the Issuer's common stock, $0.001 par value per share (\"Warrants\"). The Warrants have an exercise price of $4.11 per share, subject to customary adjustments, and will become exercisable on the six month and one day anniversary of the issuance date (the \"Initial Exercisability Date\"), and expire on the fifth (5th) anniversary of the Initial Exercisability Date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Purchase Agreement, the Reporting Person acquired 4,011 warrants to purchase 4,011 shares of the Issuer's common stock, $0.001 par value per share (\"Warrants\"). The Warrants have an exercise price of $4.11 per share, subject to customary adjustments, and will become exercisable on the six month and one day anniversary of the issuance date (the \"Initial Exercisability Date\"), and expire on the fifth (5th) anniversary of the Initial Exercisability Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Purchase Agreement, the Reporting Person acquired 4,011 warrants to purchase 4,011 shares of the Issuer's common stock, $0.001 par value per share (\"Warrants\"). The Warrants have an exercise price of $4.11 per share, subject to customary adjustments, and will become exercisable on the six month and one day anniversary of the issuance date (the \"Initial Exercisability Date\"), and expire on the fifth (5th) anniversary of the Initial Exercisability Date."}],"balance_after":4011,"derivative":{"exercise_price":4.11,"underlying":"Common Stock","underlying_shares":4011},"source":{"system":"sec-edgar","filing":"0001437749-24-023367","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774924023367/rdgdoc.xml","form_type":"4"}},{"id":1449616,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Series C Preferred Stock","published_at":"2024-07-24T21:27:47.000Z","date":"2024-07-22","kind":"grant","planned":false,"acquired":true,"shares":19,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 22, 2024, the Reporting Person acquired 19 shares of the Issuer's Series C Convertible Preferred Stock, $0.001 par value (\"Series C Preferred Stock\"), in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of July 18, 2024 (the \"Purchase Agreement\"). The shares of Series C Preferred Stock have the rights and preferences set forth on the certificate of designations of Series C Preferred Stock filed with the Secretary of State for the State of Delaware on July 19, 2024. The Series C Preferred Stock has a stated value of $1,000 per share and currently has a conversion price of $3.74 per share. The Series C Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 22, 2024, the Reporting Person acquired 19 shares of the Issuer's Series C Convertible Preferred Stock, $0.001 par value (\"Series C Preferred Stock\"), in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of July 18, 2024 (the \"Purchase Agreement\"). The shares of Series C Preferred Stock have the rights and preferences set forth on the certificate of designations of Series C Preferred Stock filed with the Secretary of State for the State of Delaware on July 19, 2024. The Series C Preferred Stock has a stated value of $1,000 per share and currently has a conversion price of $3.74 per share. The Series C Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 22, 2024, the Reporting Person acquired 19 shares of the Issuer's Series C Convertible Preferred Stock, $0.001 par value (\"Series C Preferred Stock\"), in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of July 18, 2024 (the \"Purchase Agreement\"). The shares of Series C Preferred Stock have the rights and preferences set forth on the certificate of designations of Series C Preferred Stock filed with the Secretary of State for the State of Delaware on July 19, 2024. The Series C Preferred Stock has a stated value of $1,000 per share and currently has a conversion price of $3.74 per share. The Series C Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 22, 2024, the Reporting Person acquired 19 shares of the Issuer's Series C Convertible Preferred Stock, $0.001 par value (\"Series C Preferred Stock\"), in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of July 18, 2024 (the \"Purchase Agreement\"). The shares of Series C Preferred Stock have the rights and preferences set forth on the certificate of designations of Series C Preferred Stock filed with the Secretary of State for the State of Delaware on July 19, 2024. The Series C Preferred Stock has a stated value of $1,000 per share and currently has a conversion price of $3.74 per share. The Series C Preferred Stock has no expiration date."}],"balance_after":19,"derivative":{"underlying":"Common Stock","underlying_shares":5073},"source":{"system":"sec-edgar","filing":"0001437749-24-023367","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774924023367/rdgdoc.xml","form_type":"4"}},{"id":1772323,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-09-28T11:24:59.000Z","date":"2023-09-27","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":1.0199,"value":2549.75,"ownership":{"direct":true},"balance_after":57877,"source":{"system":"sec-edgar","filing":"0001437749-23-026969","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923026969/rdgdoc.xml","form_type":"4"}},{"id":1772842,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-09-27T11:34:59.000Z","date":"2023-09-26","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":0.9,"value":2250.0,"ownership":{"direct":true},"balance_after":55377,"source":{"system":"sec-edgar","filing":"0001437749-23-026828","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923026828/rdgdoc.xml","form_type":"4"}},{"id":1796864,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-08-25T21:55:17.000Z","date":"2023-08-23","kind":"grant","planned":false,"acquired":true,"shares":68800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This employee stock option shall vest and become exercisable with respect to one-third of the total number of shares subject to the option on an annual basis (every 12 months) with the first vest date on August 23, 2024 provided that the reporting person remains in continuous service on each vesting date."}],"balance_after":68800,"derivative":{"exercise_price":1.21,"expiration_date":"2033-08-23","underlying":"Common Stock","underlying_shares":68800},"source":{"system":"sec-edgar","filing":"0001437749-23-024710","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923024710/rdgdoc.xml","form_type":"4"}},{"id":1796863,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-25T21:55:17.000Z","date":"2023-08-23","kind":"grant","planned":false,"acquired":true,"shares":45867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest with respect to one-third of the total number of shares subject to the RSUs on an annual basis (every 12 months) with the first vest date on August 23, 2024 provided that the reporting person remains in continuous service on each vesting date."}],"balance_after":52877,"source":{"system":"sec-edgar","filing":"0001437749-23-024710","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923024710/rdgdoc.xml","form_type":"4"}},{"id":1912675,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-27T11:41:36.000Z","date":"2023-04-26","kind":"purchase","planned":false,"acquired":true,"shares":1497,"price":1.77,"value":2649.69,"ownership":{"direct":true},"balance_after":7010,"source":{"system":"sec-edgar","filing":"0001437749-23-011245","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923011245/rdgdoc.xml","form_type":"4"}},{"id":1913598,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-26T11:21:45.000Z","date":"2023-04-25","kind":"purchase","planned":false,"acquired":true,"shares":1315,"price":1.89,"value":2485.35,"ownership":{"direct":true},"balance_after":5513,"source":{"system":"sec-edgar","filing":"0001437749-23-011064","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923011064/rdgdoc.xml","form_type":"4"}},{"id":1981065,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-03-03T01:27:16.000Z","date":"2023-02-28","kind":"tax_withholding","acquired":false,"shares":334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Adjusted to reflect 1-for-50 reverse stock split effective February 24, 2023."}],"balance_after":4198,"source":{"system":"sec-edgar","filing":"0001437749-23-005268","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774923005268/rdgdoc.xml","form_type":"4"}},{"id":2201465,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-07-27T20:20:55.000Z","date":"2022-07-27","kind":"purchase","acquired":true,"shares":2500,"price":0.3799,"value":949.75,"ownership":{"direct":true},"balance_after":226558,"source":{"system":"sec-edgar","filing":"0001437749-22-017890","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922017890/rdgdoc.xml","form_type":"4"}},{"id":2202038,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-07-26T20:37:01.000Z","date":"2022-07-26","kind":"purchase","acquired":true,"shares":2500,"price":0.374,"value":935.0,"ownership":{"direct":true},"balance_after":224058,"source":{"system":"sec-edgar","filing":"0001437749-22-017791","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922017791/rdgdoc.xml","form_type":"4"}},{"id":2215605,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-07-05T20:40:55.000Z","date":"2022-06-30","kind":"purchase","acquired":true,"shares":4500,"price":0.4279,"value":1925.55,"ownership":{"direct":true},"balance_after":221558,"source":{"system":"sec-edgar","filing":"0001437749-22-016607","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922016607/rdgdoc.xml","form_type":"4"}},{"id":2218900,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-06-30T10:59:36.000Z","date":"2022-06-29","kind":"purchase","acquired":true,"shares":7000,"price":0.4154,"value":2907.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple trades at prices ranging from $0.4115 to $0.4200. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":217058,"source":{"system":"sec-edgar","filing":"0001437749-22-016227","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922016227/rdgdoc.xml","form_type":"4"}},{"id":2328919,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-17T21:33:40.000Z","date":"2022-03-16","kind":"purchase","acquired":true,"shares":2000,"price":0.9799,"value":1959.8,"ownership":{"direct":true},"balance_after":210058,"source":{"system":"sec-edgar","filing":"0001437749-22-006612","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922006612/rdgdoc.xml","form_type":"4"}},{"id":2334093,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-15T20:45:36.000Z","date":"2022-03-15","kind":"purchase","acquired":true,"shares":3000,"price":0.9801,"value":2940.3,"ownership":{"direct":true},"balance_after":208058,"source":{"system":"sec-edgar","filing":"0001437749-22-006313","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922006313/rdgdoc.xml","form_type":"4"}},{"id":2348699,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-03-07T22:51:04.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":250400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This employee stock option shall vest and become exercisable with respect to one-twelfth of the total number of shares subject to the options on a quarterly basis (every three months) with the first vest date on May 31, 2022 provided that the reporting person remains in continuous service on each vesting date."}],"balance_after":250400,"derivative":{"exercise_price":1.02,"exercise_date":"2022-05-31","expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":250400},"source":{"system":"sec-edgar","filing":"0001437749-22-005417","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922005417/rdgdoc.xml","form_type":"4"}},{"id":2348698,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-07T22:51:04.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":166900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest with respect to one-third of the total number of shares subject to the RSUs on an annual basis (every 12 months) with the first vest date on February 28, 2023 provided that the reporting person remains in continuous service on each vesting date."}],"balance_after":205058,"source":{"system":"sec-edgar","filing":"0001437749-22-005417","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774922005417/rdgdoc.xml","form_type":"4"}},{"id":2501473,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-11-22T13:35:54.000Z","date":"2021-11-19","kind":"purchase","acquired":true,"shares":930,"price":1.6,"value":1488.0,"ownership":{"direct":true},"balance_after":38158,"source":{"system":"sec-edgar","filing":"0001437749-21-027198","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921027198/rdgdoc.xml","form_type":"4"}},{"id":2505430,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-11-18T21:25:25.000Z","date":"2021-11-18","kind":"purchase","acquired":true,"shares":930,"price":1.61,"value":1497.3,"ownership":{"direct":true},"balance_after":37228,"source":{"system":"sec-edgar","filing":"0001437749-21-027085","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921027085/rdgdoc.xml","form_type":"4"}},{"id":2535799,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-25T13:17:43.000Z","date":"2021-10-22","kind":"purchase","acquired":true,"shares":3000,"price":1.9,"value":5700.0,"ownership":{"direct":true},"balance_after":36298,"source":{"system":"sec-edgar","filing":"0001437749-21-024196","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921024196/rdgdoc.xml","form_type":"4"}},{"id":2539853,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-10-19T20:51:46.000Z","date":"2021-10-19","kind":"purchase","acquired":true,"shares":3000,"price":1.91,"value":5730.0,"ownership":{"direct":true},"balance_after":33298,"source":{"system":"sec-edgar","filing":"0001437749-21-023910","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921023910/rdgdoc.xml","form_type":"4"}},{"id":2744332,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-20T11:44:42.000Z","date":"2021-04-16","kind":"purchase","acquired":true,"shares":1000,"price":2.092,"value":2092.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple trades at prices ranging from $2.09 to $2.0933. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":30298,"source":{"system":"sec-edgar","filing":"0001437749-21-009306","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921009306/rdgdoc.xml","form_type":"4"}},{"id":2745958,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-19T11:47:53.000Z","date":"2021-04-15","kind":"purchase","acquired":true,"shares":1000,"price":2.2399,"value":2239.9,"ownership":{"direct":true},"balance_after":29298,"source":{"system":"sec-edgar","filing":"0001437749-21-009186","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921009186/rdgdoc.xml","form_type":"4"}},{"id":2754787,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-07T20:18:26.000Z","date":"2021-04-06","kind":"purchase","acquired":true,"shares":500,"price":2.57,"value":1285.0,"ownership":{"direct":true},"balance_after":28298,"source":{"system":"sec-edgar","filing":"0001437749-21-008459","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921008459/rdgdoc.xml","form_type":"4"}},{"id":2756133,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-06T20:28:13.000Z","date":"2021-04-05","kind":"purchase","acquired":true,"shares":1000,"price":2.5799,"value":2579.9,"ownership":{"direct":true},"balance_after":27798,"source":{"system":"sec-edgar","filing":"0001437749-21-008400","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921008400/rdgdoc.xml","form_type":"4"}},{"id":2758966,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-04-05T12:06:27.000Z","date":"2021-04-01","kind":"purchase","acquired":true,"shares":500,"price":2.4587,"value":1229.35,"ownership":{"direct":true},"balance_after":26798,"source":{"system":"sec-edgar","filing":"0001437749-21-008159","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921008159/rdgdoc.xml","form_type":"4"}},{"id":2767099,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-31T20:30:02.000Z","date":"2021-03-31","kind":"purchase","acquired":true,"shares":500,"price":2.3199,"value":1159.95,"ownership":{"direct":true},"balance_after":26298,"source":{"system":"sec-edgar","filing":"0001437749-21-007852","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921007852/rdgdoc.xml","form_type":"4"}},{"id":2772410,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock Warrants","published_at":"2021-03-25T20:43:13.000Z","date":"2021-03-25","kind":"purchase","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the purchase of shares of common stock on March 25, 2021 as reported above."}],"balance_after":1500,"derivative":{"exercise_price":3.6,"exercise_date":"2021-03-25","expiration_date":"2026-03-25","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001437749-21-007171","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921007171/rdgdoc.xml","form_type":"4"}},{"id":2772409,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-03-25T20:43:13.000Z","date":"2021-03-25","kind":"purchase","acquired":true,"shares":1500,"price":3.25,"value":4875.0,"ownership":{"direct":true},"balance_after":25798,"source":{"system":"sec-edgar","filing":"0001437749-21-007171","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921007171/rdgdoc.xml","form_type":"4"}},{"id":2896232,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-01-26T21:34:21.000Z","date":"2021-01-22","kind":"grant","acquired":true,"shares":143250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This employee stock option shall vest in a series of three successive, equal installments beginning with the first anniversary of the grant date."}],"balance_after":143250,"derivative":{"exercise_price":5.44,"exercise_date":"2022-01-22","expiration_date":"2031-01-22","underlying":"Common Stock","underlying_shares":143250},"source":{"system":"sec-edgar","filing":"0001437749-21-001282","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921001282/rdgdoc.xml","form_type":"4"}},{"id":2896231,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-01-26T21:34:21.000Z","date":"2021-01-22","kind":"grant","acquired":true,"shares":143250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This employee stock option shall vest in a series of three successive, equal installments on the grant date and the first and second anniversaries of the grant date."}],"balance_after":143250,"derivative":{"exercise_price":5.44,"exercise_date":"2021-01-22","expiration_date":"2031-01-22","underlying":"Common Stock","underlying_shares":143250},"source":{"system":"sec-edgar","filing":"0001437749-21-001282","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774921001282/rdgdoc.xml","form_type":"4"}},{"id":2998295,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-10-29T10:08:32.000Z","date":"2020-10-28","kind":"purchase","acquired":true,"shares":250,"price":6.5595,"value":1639.875,"ownership":{"direct":true},"balance_after":24298,"source":{"system":"sec-edgar","filing":"0001437749-20-021886","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774920021886/rdgdoc.xml","form_type":"4"}},{"id":3008633,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-10-13T12:40:56.000Z","date":"2020-10-09","kind":"purchase","acquired":true,"shares":250,"price":5.825,"value":1456.25,"ownership":{"direct":true},"balance_after":24048,"source":{"system":"sec-edgar","filing":"0001437749-20-021048","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774920021048/rdgdoc.xml","form_type":"4"}},{"id":3009578,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-10-09T12:05:03.000Z","date":"2020-10-07","kind":"purchase","acquired":true,"shares":250,"price":5.17,"value":1292.5,"ownership":{"direct":true},"balance_after":23798,"source":{"system":"sec-edgar","filing":"0001437749-20-020956","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774920020956/rdgdoc.xml","form_type":"4"}},{"id":3134295,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock Warrants","published_at":"2020-05-28T01:44:21.000Z","date":"2020-05-22","kind":"purchase","acquired":true,"shares":2069,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Issued in connection with the purchase of shares of common stock on May 22, 2020 as reported above."}],"balance_after":2069,"derivative":{"exercise_price":7.975,"exercise_date":"2020-05-22","expiration_date":"2025-05-22","underlying":"Common Stock","underlying_shares":2069},"source":{"system":"sec-edgar","filing":"0001437749-20-011874","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774920011874/rdgdoc.xml","form_type":"4"}},{"id":3134294,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-05-28T01:44:21.000Z","date":"2020-05-22","kind":"purchase","acquired":true,"shares":2069,"price":7.25,"value":15000.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Adjusted to reflect 1-for-3 reverse stock split effective April 29, 2020."}],"balance_after":23548,"source":{"system":"sec-edgar","filing":"0001437749-20-011874","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774920011874/rdgdoc.xml","form_type":"4"}},{"id":3134349,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-05-28T01:28:54.000Z","date":"2019-03-15","kind":"tax_withholding","acquired":false,"shares":18023,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":63337,"source":{"system":"sec-edgar","filing":"0001437749-20-011862","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774920011862/rdgdoc.xml","form_type":"4/A","original_submission_date":"2019-03-19"}},{"id":3134279,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-05-28T01:22:49.000Z","date":"2019-02-07","kind":"tax_withholding","acquired":false,"shares":18175,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":81360,"source":{"system":"sec-edgar","filing":"0001437749-20-011861","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774920011861/rdgdoc.xml","form_type":"4/A","original_submission_date":"2019-02-11"}},{"id":3134278,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-05-28T01:22:49.000Z","date":"2019-02-07","kind":"grant","acquired":true,"shares":98810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions relate to the cancellation of a restricted stock unit (RSU) award originally granted on November 1, 2017, and the immediate re-issuance of replacement RSUs and common stock on substantially the same economic terms."}],"balance_after":99535,"source":{"system":"sec-edgar","filing":"0001437749-20-011861","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774920011861/rdgdoc.xml","form_type":"4/A","original_submission_date":"2019-02-11"}},{"id":3134277,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-05-28T01:22:49.000Z","date":"2019-02-07","kind":"disposition_to_issuer","acquired":false,"shares":83257,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions relate to the cancellation of a restricted stock unit (RSU) award originally granted on November 1, 2017, and the immediate re-issuance of replacement RSUs and common stock on substantially the same economic terms."}],"balance_after":725,"source":{"system":"sec-edgar","filing":"0001437749-20-011861","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774920011861/rdgdoc.xml","form_type":"4/A","original_submission_date":"2019-02-11"}},{"id":3277949,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-02-12T21:07:35.000Z","date":"2020-02-11","kind":"purchase","acquired":true,"shares":250,"price":4.1,"value":1025.0,"ownership":{"direct":true},"balance_after":63590,"source":{"system":"sec-edgar","filing":"0001437749-20-002448","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774920002448/rdgdoc.xml","form_type":"4"}},{"id":3277948,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-02-12T21:07:35.000Z","date":"2020-02-10","kind":"purchase","acquired":true,"shares":250,"price":4.1,"value":1025.0,"ownership":{"direct":true},"balance_after":63340,"source":{"system":"sec-edgar","filing":"0001437749-20-002448","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774920002448/rdgdoc.xml","form_type":"4"}},{"id":3289514,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-02-05T21:14:24.000Z","date":"2020-02-04","kind":"purchase","acquired":true,"shares":500,"price":4.24,"value":2120.0,"ownership":{"direct":true},"balance_after":63090,"source":{"system":"sec-edgar","filing":"0001437749-20-001792","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774920001792/rdgdoc.xml","form_type":"4"}},{"id":3289513,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-02-05T21:14:24.000Z","date":"2020-02-03","kind":"purchase","acquired":true,"shares":100,"price":4.2,"value":420.0,"ownership":{"direct":true},"balance_after":62590,"source":{"system":"sec-edgar","filing":"0001437749-20-001792","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774920001792/rdgdoc.xml","form_type":"4"}},{"id":3583713,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-03-21T20:34:49.000Z","date":"2019-03-19","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This employee stock option shall vest in a series of three successive, equal installments beginning with the first anniversary of the grant."}],"balance_after":100000,"derivative":{"exercise_price":4.3,"exercise_date":"2020-03-19","expiration_date":"2029-03-19","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-19-005428","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774919005428/rdgdoc.xml","form_type":"4"}},{"id":3588920,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-03-19T22:04:27.000Z","date":"2019-03-15","kind":"tax_withholding","acquired":false,"shares":20641,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":62490,"source":{"system":"sec-edgar","filing":"0001437749-19-005304","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774919005304/rdgdoc.xml","form_type":"4"}},{"id":3666478,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-02-12T02:33:17.000Z","date":"2019-02-07","kind":"tax_withholding","acquired":false,"shares":16404,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":83131,"source":{"system":"sec-edgar","filing":"0001437749-19-002270","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774919002270/rdgdoc.xml","form_type":"4"}},{"id":3666477,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-02-12T02:33:17.000Z","date":"2019-02-07","kind":"grant","acquired":true,"shares":98810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions relate to the cancellation of a restricted stock unit (RSU) award originally granted on November 1, 2017, and the immediate re-issuance of replacement RSUs and common stock on substantially the same economic terms."}],"balance_after":99535,"source":{"system":"sec-edgar","filing":"0001437749-19-002270","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774919002270/rdgdoc.xml","form_type":"4"}},{"id":3666476,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-02-12T02:33:17.000Z","date":"2019-02-07","kind":"disposition_to_issuer","acquired":false,"shares":83257,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions relate to the cancellation of a restricted stock unit (RSU) award originally granted on November 1, 2017, and the immediate re-issuance of replacement RSUs and common stock on substantially the same economic terms."}],"balance_after":725,"source":{"system":"sec-edgar","filing":"0001437749-19-002270","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774919002270/rdgdoc.xml","form_type":"4"}},{"id":3714760,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-01-02T22:10:00.000Z","date":"2018-12-28","kind":"tax_withholding","acquired":false,"shares":15553,"price":5,"value":77765.0,"ownership":{"direct":true},"balance_after":83982,"source":{"system":"sec-edgar","filing":"0001437749-19-000096","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774919000096/rdgdoc.xml","form_type":"4"}},{"id":3718403,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-28T00:12:18.000Z","date":"2018-12-24","kind":"grant","acquired":true,"shares":1265717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This employee stock option shall vest in a series of three successive, annual installments beginning with the first anniversary of the grant date."}],"balance_after":1265717,"derivative":{"exercise_price":4.22,"exercise_date":"2019-12-24","expiration_date":"2028-12-24","underlying":"Common Stock","underlying_shares":1265717},"source":{"system":"sec-edgar","filing":"0001437749-18-022672","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774918022672/rdgdoc.xml","form_type":"4"}},{"id":3754032,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Series A Convertible Preferred Stock","published_at":"2018-11-24T02:48:00.000Z","date":"2018-11-21","kind":"exercise","acquired":false,"shares":7,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Adjusted to reflect 1-for-20 reverse stock split effective December 22, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Series A Convertible Preferred Stock (Preferred Stock) originally acquired in a unit offering consisting of Preferred Stock and a warrant at a unit price of $1,495. Each unit consists of one share of Series A Convertible Preferred Stock, which is convertible without additional consideration into 50 shares of the Company's common stock, and 50 Series A-1 seven-year warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Series A Convertible Preferred Stock was immediately convertible and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Series A Convertible Preferred Stock was immediately convertible and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Adjusted to reflect 1-for-20 reverse stock split effective December 22, 2017."}],"balance_after":0,"derivative":{"exercise_price":27.4,"underlying":"Common Stock","underlying_shares":350},"source":{"system":"sec-edgar","filing":"0001437749-18-021250","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774918021250/rdgdoc.xml","form_type":"4"}},{"id":3754031,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-11-24T02:48:00.000Z","date":"2018-11-21","kind":"exercise","acquired":true,"shares":350,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Series A Convertible Preferred Stock (Preferred Stock) originally acquired in a unit offering consisting of Preferred Stock and a warrant at a unit price of $1,495. Each unit consists of one share of Series A Convertible Preferred Stock, which is convertible without additional consideration into 50 shares of the Company's common stock, and 50 Series A-1 seven-year warrants."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Adjusted to reflect 1-for-20 reverse stock split effective December 22, 2017."}],"balance_after":99535,"source":{"system":"sec-edgar","filing":"0001437749-18-021250","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774918021250/rdgdoc.xml","form_type":"4"}},{"id":4173541,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-11-03T13:29:43.000Z","date":"2017-11-01","kind":"grant","acquired":true,"shares":1976190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock, having a value when issued equal to the combined total value of the 2017 and 2018 Target Bonus Amounts (as defined in the executive's employment agreement).  The RSUs shall vest in two equal installments on March 15, 2018 and March 15, 2019."}],"balance_after":1983690,"source":{"system":"sec-edgar","filing":"0001437749-17-018209","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774917018209/rdgdoc.xml","form_type":"4"}},{"id":4405974,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2017-03-03T21:16:27.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This employee stock option shall vest in a series of three successive, equal installments beginning with the first anniversary of the grant."}],"balance_after":100000,"derivative":{"exercise_price":1.23,"exercise_date":"2018-03-01","expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-17-003777","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774917003777/rdgdoc.xml","form_type":"4"}},{"id":4446475,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Series A-1 Warrants (Right to Buy)","published_at":"2017-02-15T22:09:46.000Z","date":"2017-02-13","kind":"purchase","acquired":true,"shares":7000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Series A-1 Warrants in connection with the purchase of Series A Convertible Preferred Stock units acquired in a private placement offering with a unit price of $1,495. Each unit consists of one share of Series A Convertible Preferred Stock, which is convertible into 1,000 shares of the Company's common stock, and 1,000 Series A-1 seven-year warrants to purchase one share of the Company's common stock at an exercise price of $1.37."}],"balance_after":7000,"derivative":{"exercise_price":1.37,"exercise_date":"2017-08-15","expiration_date":"2024-08-15","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001437749-17-002590","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774917002590/rdgdoc.xml","form_type":"4"}},{"id":4446474,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Series A Convertible Preferred Stock","published_at":"2017-02-15T22:09:46.000Z","date":"2017-02-13","kind":"purchase","acquired":true,"shares":7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Series A Convertible Preferred Stock in connection with the purchase of Series A Convertible Preferred Stock units acquired in a private placement offering with a unit price of $1,495. Each unit consists of one share of Series A Convertible Preferred Stock, which is convertible into 1,000 shares of the Company's common stock, and 1,000 Series A-1 seven-year warrants to purchase one share of the Company's common stock at an exercise price of $1.37."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Series A Convertible Preferred Stock is immediately exercisable and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Series A Convertible Preferred Stock is immediately exercisable and has no expiration date."}],"balance_after":7,"derivative":{"exercise_price":1.37,"underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001437749-17-002590","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774917002590/rdgdoc.xml","form_type":"4"}},{"id":4571163,"issuer":{"id":8761,"kind":"organization","name":"WINDTREE THERAPEUTICS INC /DE/"},"owners":[{"id":86889,"kind":"person","name":"Fraser Craig","position":1,"cik":"0001557420","reported_name":"Fraser Craig","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-11-01T12:27:58.000Z","date":"2016-10-28","kind":"purchase","acquired":true,"shares":7500,"price":2.0508,"value":15381.0,"ownership":{"direct":true},"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001437749-16-040698","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/946486/000143774916040698/rdgdoc.xml","form_type":"4"}}]}